Literature DB >> 2349368

Calcium channel blockers: effect on morphine-induced hypermotility.

M I Martin1, I Lizasoain, J C Leza.   

Abstract

Acute morphine treatment has been shown to cause a uniform calcium depletion in various brain regions and to evoke hypermotility in mice. On the other hand, it has been reported previously that calcium channel blockers reduce the behavioral stimulation induced by different methods in mice, and it is known that these drugs increase the morphine analgesia and reduce the abstinence syndrome. The effect of calcium channel blockers, nifedipine and diltiazem, on the morphine- and amphetamine-induced hypermotility were evaluated. Mice activity was measured with photocell motility meters. The results show that neither nifedipine nor diltiazem decrease significantly the motility in control and amphetamine-treated mice; however, when they were administered to morphine-treated mice the hypermotility was significantly reduced. The mechanism responsible for this interference is still unknown.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2349368     DOI: 10.1007/bf02244138

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice.

Authors:  J A Grebb
Journal:  Life Sci       Date:  1986-06-30       Impact factor: 5.037

2.  Effects of acute and chronic morphine treatments on calcium localization and binding in brain.

Authors:  H Yamamoto; R A Harris; H H Loh; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1978-05       Impact factor: 4.030

3.  Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists.

Authors:  G Benedek; M Szikszay
Journal:  Pharmacol Res Commun       Date:  1984-10

4.  The behavioral effects of the calcium agonist Bay K 8644 in the mouse: antagonism by the calcium antagonist nifedipine.

Authors:  G T Bolger; B A Weissman; P Skolnick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

5.  Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors?

Authors:  Y F Jacquet; W A Klee; K C Rice; I Iijima; J Minamikawa
Journal:  Science       Date:  1977-11-25       Impact factor: 47.728

6.  Tripelennamine enhances buprenorphine-, but not pentazocine-induced hyperactivity in mice.

Authors:  M Sansone; C Castellano; V Libri
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence.

Authors:  V Ramkumar; E E el-Fakahany
Journal:  Eur J Pharmacol       Date:  1988-01-27       Impact factor: 4.432

8.  Decrease in analgesic effect of nifedipine following chronic morphine administration.

Authors:  T Ohnishi; K Saito; K Matsumoto; M Sakuda; R Inoki
Journal:  Eur J Pharmacol       Date:  1988-12-06       Impact factor: 4.432

9.  Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance.

Authors:  E Contreras; L Tamayo; M Amigo
Journal:  Eur J Pharmacol       Date:  1988-04-13       Impact factor: 4.432

10.  Differences between calcium channel inhibitors in their effects on phencyclidine-induced behavioral stimulation in mice.

Authors:  J A Grebb; K A Ellsworth; W J Freed
Journal:  Pharmacol Biochem Behav       Date:  1985-10       Impact factor: 3.533

View more
  3 in total

1.  Role of sodium cromoglycate on analgesia, locomotor activity and opiate withdrawal in mice.

Authors:  J C Leza; I Lizasoain; O S Martín-Clark; P Lorenzo
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Facilitation of shuttle-box avoidance behaviour in mice treated with nifedipine in combination with amphetamine.

Authors:  J Vetulani; M Battaglia; C Castellano; M Sansone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Changes induced by sodium cromoglycate in brain catecholamine turnover in morphine dependent and abstinent mice.

Authors:  O San-Martín-Clark; B Cuéllar; J De Alba; J C Leza; P Lorenzo
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.